Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors
Clinical Scorecard: Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Ophthalmology clinics, surgical centers, and inpatient facilities
Key Highlights
Add specific data or statistics on efficacy and safety outcomes.
Guideline-Based Recommendations
Diagnosis
Management
Consider PreserFlo MicroShunt for patients with contraindications to trabeculectomy, including specific contraindications.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
PreserFlo MicroShunt may reduce the need for antiglaucoma medications compared to trabeculectomy, supported by specific studies.
Clinical Best Practices
Utilize a standardized protocol for patient selection and surgical technique, detailing specific criteria.
